Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women
Sign Up to like & getrecommendations! Published in 2018 at "American Journal of Obstetrics and Gynecology"
DOI: 10.1016/j.ajog.2017.12.221
Abstract: BACKGROUND: Population‐based BRCA1/BRCA2 founder‐mutation testing has been demonstrated as cost effective compared with family history based testing in Ashkenazi Jewish women. However, only 1 of the 3 Ashkenazi Jewish BRCA1/BRCA2 founder mutations (185delAG[c.68_69delAG]), 5382insC[c.5266dupC]), and… read more here.
Keywords: population based; jewish women; sephardi jewish; cost effectiveness ... See more keywords